Chemist Jeffrey Winkler Elected to John Morgan Society

Professor of Chemistry Jeffrey Winkler has been elected to the John Morgan Society of the University of Pennsylvania.  The Morgan Society, the oldest honorific biomedical society in the country, was founded to stimulate research in basic medical science by promoting favorable conditions for such investigations through fostering communication between its members.

Winkler’s research in organic chemistry focuses on finding new and better ways of synthesizing drugs. He was involved in developing the anticancer drug Taxol and a more effective version of Ritalin, used for treating hyperactive children. His research has been recognized with numerous awards and honors, including the American Chemical Society Cope Scholar Award and an Alfred P. Sloan Foundation Fellowship. 

Winkler has authored 75 publications and given more than 80 invited lectures to major pharmaceutical and biotechnology companies. He is a founding member of Penn’s Center for Cancer Pharmacology and is active in several cancer associations and societies. He has served as a member of the Scientific Advisory Board of PolyMedix Inc. and as an expert consultant at leading law firms on a variety of chemical issues. Winkler holds a doctorate in chemistry from Columbia University and a B.S. in chemistry from Harvard University.